Next Article in Journal
Molecular Tuning of IR-786 for Improved Tumor Imaging and Photothermal Therapy
Next Article in Special Issue
Targeting Zika Virus with New Brain- and Placenta-Crossing Peptide–Porphyrin Conjugates
Previous Article in Journal
PLA2-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy
Previous Article in Special Issue
Injectable Biodegradable Silica Depot: Two Months of Sustained Release of the Blood Glucose Lowering Peptide, Pramlintide
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(3), 672; https://doi.org/10.3390/pharmaceutics14030672
Action Date Notes Link
article xml file uploaded 18 March 2022 14:09 CET Original file -
article xml uploaded. 18 March 2022 14:09 CET Update https://www.mdpi.com/1999-4923/14/3/672/xml
article pdf uploaded. 18 March 2022 14:09 CET Version of Record https://www.mdpi.com/1999-4923/14/3/672/pdf
article html file updated 18 March 2022 14:10 CET Original file -
article html file updated 1 August 2022 06:27 CEST Update https://www.mdpi.com/1999-4923/14/3/672/html
Back to TopTop